window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 8, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Opinion & Events

  • Biotech & Pharma Business,Clinical & Regulatory,Opinion & Events,Therapeutic Areas

    Abivax to present nine obefazimod studies at DDW as Phase 3 ulcerative colitis data build

    Abivax will present nine scientific abstracts on obefazimod at Digestive [...]

    May 5, 2026
  • Central Nervous System,Clinical & Regulatory,Drug Delivery & Formulation,Drug Discovery & Development,Opinion & Events,Therapeutic Areas

    Emalex secures US patent for ecopipam orally disintegrating tablet in Tourette syndrome

    Emalex Biosciences has secured a US patent for an orally [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Opinion & Events

    Phesi data highlights 6.7% of global clinical trials affected by Middle East disruption

    New analysis from Phesi suggests 6.7% of globally recruiting clinical [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Opinion & Events

    Strong scientists: PHARMExcel’s Margaret Irwin on clinical research careers and early stage trials

    From hospital haematology to leading early stage clinical trials, Margaret [...]

    May 5, 2026
  • Drug Discovery & Development,Manufacturing & Supply Chain,Opinion & Events,Pharmaceuticals and therapeutics

    Fujifilm Biotechnologies unveils ShunzymeX purification technology for biologics

    FUJIFILM Biotechnologies has unveiled ShunzymeX, a purification technology designed to [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Opinion & Events,Therapeutic Areas

    ViiV Healthcare reports 12-month data showing lotivibart maintains viral suppression in ultra long-acting HIV regimen

    ViiV Healthcare, the global specialist HIV company majority owned by [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Opinion & Events,Therapeutic Areas

    Young adults in US, UK and Australia hit hardest by global mental health decline

    Young adults in wealthy countries are four times more likely [...]

    May 5, 2026
  • Central Nervous System,Clinical & Regulatory,Drug Discovery & Development,Opinion & Events,Therapeutic Areas

    International Brain Health Conference 2026 to focus on early intervention before dementia

    The inaugural International Brain Health Conference 2026 in Edinburgh will [...]

    May 5, 2026
  • Drug Discovery & Development,Manufacturing & Supply Chain,Opinion & Events

    HORIBA to build new global headquarters to strengthen operations and drive innovation

    HORIBA, Ltd., a global leader in analytical and measurement instrumentation [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Opinion & Events,Pharmaceuticals and therapeutics,Therapeutic Areas

    BNPP AM Alts invests $115M in ILiAD Biotechnologies to advance whooping cough vaccine

    BNP Paribas Asset Management Alts (BNPP AM Alts) has made [...]

    May 5, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Trelleborg gains ISO certification for Costa Rica medtech plant
    Categories: Clinical & Regulatory, Manufacturing & Supply Chain, Medical devices
  • Merck launches bio-based HPLC solvents for pharma labs
    Categories: Drug Discovery & Development, Manufacturing & Supply Chain
  • Alto starts Phase 2b ALTO-207 trial in treatment-resistant depression
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top